Limestone Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Hold
600
0.02% 296
2025
Q4
$196K Buy
+600
New +$190K 0.02% 340
2025
Q3
Sell
-16,500
Closed -$4.61M 538
2025
Q2
$4.61M Buy
+16,500
New +$4.67M 0.4% 53

Other funds holding AMGN

Limestone Investment Advisors's AMGN Position: Q1 2026 in Review

Limestone Investment Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 320 shares — an estimated $114K sold.

Limestone Investment Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $105K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Limestone Investment Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Limestone Investment Advisors sold 320 Amgen shares in Q1 2026, an estimated $114K.
  • Limestone Investment Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
  • Limestone Investment Advisors's Amgen position peaked at $105K in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Limestone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.